Tag: Kedrion

The global albumin market is dominated by a handful of key players, with major pharmaceutical and biotechnology firms manufacturing albumin from human plasma or through recombinant technology. This vital medication supports many medical applications, from critical care to disease management. Let's explore who manufactures albumin and the intricate processes involved in its production.

Prior to the development of anti-D immune globulin in the 1960s, hemolytic disease of the fetus and newborn (HDFN) was a significant risk in Rh-incompatible pregnancies. This groundbreaking medication, widely known as RhoGAM, comes from a highly specialized process utilizing donated human plasma containing crucial anti-D antibodies.